Clark & Stuart Inc’s Organon & Co OGN Stock Holding History

Clark & Stuart Inc’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-29,126	Closed	-$434K	–	49
2025 Q1	$434K	Hold	29,126	–	–	0.32%	35
2024 Q4	$435K	Buy	+29,126	New	+$475K	0.32%	35

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Clark & Stuart Inc's OGN Position: Q2 2025 in Review

Clark & Stuart Inc sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 29,126 shares — an estimated $434K sold.

Clark & Stuart Inc first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $435K in Q4 2024. 694 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Clark & Stuart Inc reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Clark & Stuart Inc sold 29,126 Organon & Co shares in Q2 2025, an estimated $434K.
Clark & Stuart Inc first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
Clark & Stuart Inc's Organon & Co position peaked at $435K in Q4 2024.
694 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Clark & Stuart Inc's 13F filing for Q2 2025, filed 23 Jul 2025.